China Pharma | 10-K: Annual report
Apr 1 16:15 ET
China Pharma | 8-K: Current report
Mar 29 16:09 ET
China Pharma | 8-K: Current report
Feb 23 16:11 ET
China Pharma | EFFECT: Others
Feb 15 06:07 ET
China Pharma | CORRESP: CORRESP
Feb 14 12:43 ET
China Pharma | 8-K: Current report
Feb 8 16:09 ET
China Pharma | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)
Feb 6 16:20 ET
China Pharma | CORRESP: CORRESP
Feb 6 12:43 ET
China Pharma | 3: Initial statement of beneficial ownership of securities-10% Owner Liu Tao (Chengdu)
Jan 26 17:06 ET
China Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Tao Liu(27.3%)
Jan 26 17:06 ET
China Pharma | UPLOAD: Others
Jan 25 12:43 ET
China Pharma | S-3: Registration statement for specified transactions by certain issuers
Jan 12 00:00 ET
China Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Streeterville Capital LLC(9.99*%),Streeterville Management LLC(9.99*%), etc.
Jan 12 00:00 ET
China Pharma | 8-K: Current report
Dec 21, 2023 16:05 ET
China Pharma | 8-K: Current report
Dec 19, 2023 16:05 ET
China Pharma | UPLOAD: Others
Nov 16, 2023 16:36 ET
China Pharma: Q3 2023 Earnings Report
Nov 13, 2023 16:05 ET
China Pharma | CORRESP: CORRESP
Nov 9, 2023 20:32 ET
China Pharma | DEF 14A: Definitive information statements
Nov 7, 2023 16:05 ET
China Pharma | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Oct 27, 2023 16:06 ET
No Data
No Data